HKEX:2616

CStone Pharmaceuticals Stock Insider Trading

Hong Kong Stock Exchange > Healthcare > Biotechnology

HK$1.14

+0.0300 (+2.70%)

At Close: Jun 28, 2024

CStone Pharmaceuticals Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 2616.HK shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About CStone Pharmaceuticals

CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and internationally. It offers Sugemalimab, a monoclonal antibody against programmed death (PD) ligand 1; GAVRETO, an RET inhibitor for the treatment of patients with advanced or metastatic RET-mutant medullary and RET fusion-positive thyroid cancers; a... 2616.HK Profile

Golden Star

Ticker	Date	Change	Price
FFIV	Jun 26	1.75%	$169.26
VIGI	Jun 26	0.694%	$80.72
EHC	Jun 25	1.08%	$84.87
SNAP	Jun 24	6.00%	$15.67
EVBG	Jun 21	0.662%	$34.76
DDOG	Jun 21	10.31%	$117.57
SRE	Jun 20	0.768%	$75.48
PEG	Jun 20	0.163%	$73.58
DOC	Jun 20	1.14%	$19.38
EPD	Jun 18	2.40%	$28.30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In